AnPac Bio-Medical Science Co. Announces 5 Million Private Placement
ANPCDelisted Stock | USD 4.37 0.20 4.38% |
About 62% of Anpac Bio's investor base is looking to short. The analysis of current outlook of investing in Anpac Bio Medical suggests that many traders are alarmed regarding Anpac Bio's prospects. The current market sentiment, together with Anpac Bio's historical and current headlines, can help investors time the market. In addition, many technical investors use Anpac Bio Medical stock news signals to limit their universe of possible portfolio assets.
Anpac |
AnPac Bio-Medical Science Co. Announces 5 Million Private Placement
Read at investing.com
Anpac Bio Fundamental Analysis
We analyze Anpac Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Anpac Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Anpac Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Debt
Total Debt Comparative Analysis
Anpac Bio is currently under evaluation in total debt category among its peers. Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Anpac Bio Medical Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Anpac Bio stock to make a market-neutral strategy. Peer analysis of Anpac Bio could also be used in its relative valuation, which is a method of valuing Anpac Bio by comparing valuation metrics with similar companies.
Peers
Anpac Bio Related Equities
PMVP | Pmv Pharmaceuticals | 4.32 | ||||
MRKR | Marker Therapeutics | 4.00 | ||||
LUMO | Lumos Pharma | 1.86 | ||||
AVTE | Aerovate Therapeutics | 1.14 | ||||
ANEB | Anebulo Pharmaceuticals | 0.70 | ||||
OPT | Opthea | 0.54 | ||||
ALRN | Aileron Therapeutics | 0.35 | ||||
ABVC | ABVC Biopharma | 1.32 | ||||
CELC | Celcuity LLC | 1.33 | ||||
HOWL | Werewolf Therapeutics | 2.00 | ||||
ACRV | Acrivon Therapeutics, | 2.11 | ||||
ANTX | AN2 Therapeutics | 4.19 | ||||
EWTX | Edgewise Therapeutics | 4.42 | ||||
CCCC | C4 Therapeutics | 5.49 | ||||
PTIX | Protagenic Therapeutics | 20.34 | ||||
XCUR | Exicure | 24.38 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Consideration for investing in Anpac Stock
If you are still planning to invest in Anpac Bio Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Anpac Bio's history and understand the potential risks before investing.
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |